]>
IRCT20180102038188N1 IRCT 2018-06-13 Sabzevar University of Medical Sciences The effect of TCA (20%) trichloroacetic acid and topical combination of steroid and tretinoin in macular amyloidosis Comparison of the effect of TCA (20%) trichloroacetic acid and topical combination of steroid and tretinoin in macular amyloidosis; a double blind clinical trial. 2018-06-05 anticipated 20 Complete https://irct.ir/trial/30497 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block randomization method based on gender and using PASS software will be used in this study, Blinding description: In this double-blind study, patients and outcome evaluators who is dermatologist will be kept blind. 3 Macular amyloidosis. Intervention 1: Intervention group: Given that the disease is a sympathetic disease, on one side of the body, TCA 20% will be used. This intervention will be done for three one month periods. Intervention 2: Control group: In this group, routine treatment including topical composition containing triamcinolone 15 grams and tretinoin 15 grams) will be performed for the other side of the back. This intervention will be done for three one month periods. Yes - There is a plan to make this available What will be shared: In this study, only a portion of the data will be shared, such as the primary and secondary outcomes. When: Get started since 1398 To whom: This study will be available to all people in the community. Conditions: - Where to obtain: Dr Maryam Karabi, Sabzevar University of Medical Sciences. How to obtain: Contact with Research and Technology Unit of Sabzevar University of Medical Sciences Comments: -
public Maryam Karabi
Vasei Hospital, Towhid Shahr Road
sabzevar Iran (Islamic Republic of) 9613873137 +98 21 4401 8317 arezomande90@medsab.ac.ir Sabzevar University of Medical Sciences scientific Maryam Karabi
Vasei Hospital, Towhid Shahr Road
Sabzevar Iran (Islamic Republic of) 9613873137 +98 21 4401 8317 arezomande90@medsab.ac.ir Sabzevar University of Medical Sciences Iran (Islamic Republic of) Patients with macular amyloidosis referring to dermatology clinic of Sabzevar Vasei Hospital Being at the age of 25 to 45 years Satisfaction to participate in the study 25 years 45 years Both Treatment - Drugs Treatment - Drugs Intervention group: Given that the disease is a sympathetic disease, on one side of the body, TCA 20% will be used. This intervention will be done for three one month periods. Control group: In this group, routine treatment including topical composition containing triamcinolone 15 grams and tretinoin 15 grams) will be performed for the other side of the back. This intervention will be done for three one month periods. Cutaneous pigmentation. Timepoint: 0, 1, 2 and 3 months later. Method of measurement: Checklist completed by dermatologist. -. Timepoint: -. Method of measurement: -. Sabzevar University of Medical Sciences Approved 2018-03-05 Ethics committee of Sabzevar University of Medical Sciences Sabzevar University of Medical Sciences, Tohid Shahr Sabzevar Razavi Khorasan Iran (Islamic Republic of)